Dear Partners -

As our holiday week in Japan comes to a close, we have had time to reflect on the two months since the earthquake and resulting tsunami. Our team of 130 employees in Tokyo were fortunate to have no direct relatives caught in the destructive path of the disasters that devastated the northern three prefectures. Our company was able to continuously operate during the days after the disaster by working from our homes with M3’s web based systems - which were recently ISO certified in the USA. Golden Week – a week of Japanese national holidays - was a time to reflect on how privileged we all are around the world and welcome the spring season, a time of revitalization. Officially, we are now back at full strength, 100% capacity and working from our offices, and ready to service your projects in Japan. Consider us OPEN for business.

Since the disaster, we have been allowing our global physicians to donate their earned honoraria and employees to donate their pay. We are happy to report we have raised and donated over $1,000,000 to the American Red Cross, Red Cross – EU, and Japanese Red Cross. If you are a client that has done a project with us in 2011 – THANK YOU for making it possible to raise this donation by trusting us with your research! We will continue to allow physicians around the world to donate their honoraria through the end of the year. By using the M3 Global Research panel you will be able to help relief efforts everyday!

Perhaps you'd "LIKE" to join us and help M3 contribute to the Japanese relief efforts? We recently launched a new Facebook page at www.facebook.com/m3globalresearch Simply LIKE M3 Global Research on our page then share with your friends to get them involved. We will donate $1 to the American Red Cross for every LIKE registered before May 31, 2011!

Thank you again for both your patience and confidence in our Tokyo based company. We look forward to working with you again, at full speed, in Japan!

M3 Global Research is the market research division of Tokyo-based M3 Inc. (JP:2413) operating globally with a proprietary healthcare professionals panel of 1.3 million respondents in more than 60 countries. The division was created by uniting the worldwide panels of MDLinx in the USA, EMS Research in Europe, and M3 companies across Asia. M3 Global Research offers a broad range of capabilities including quantitative, qualitative, and omnibus surveys utilizing call centers and in-country project managers. M3 has provided solutions for every top 20 pharmaceutical company in the world. For more information, visit http://research.m3.com or email requests in the USA to research@usa.m3.com , in Europe to research@eu.m3.com, and in Asia to research@m3.com